ATE135928T1 - Elektrolytische zuführung von polypeptiden durch die haut - Google Patents

Elektrolytische zuführung von polypeptiden durch die haut

Info

Publication number: ATE135928T1
Authority: AT; Austria
Prior art keywords: polypeptide; aqueous; skin; patient; suspension
Prior art date: 1987-02-10

Application number

AT88101857T

Other languages

English (en)

Inventor

Dan Sibalis

Sanford Rosen

Original Assignee

Drug Delivery Systems Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-10

Filing date

1988-02-09

Publication date

1996-04-15

1988-02-09 Application filed by Drug Delivery Systems Inc filed Critical Drug Delivery Systems Inc

1996-04-15 Application granted granted Critical

1996-04-15 Publication of ATE135928T1 publication Critical patent/ATE135928T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
229920001184 polypeptide Polymers 0.000 title abstract 6
102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
BJFIDCADFRDPIO-DZCXQCEKSA-N (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1 BJFIDCADFRDPIO-DZCXQCEKSA-N 0.000 abstract 1
CUKWUWBLQQDQAC-VEQWQPCFSA-N (3s)-3-amino-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-ox Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 CUKWUWBLQQDQAC-VEQWQPCFSA-N 0.000 abstract 1
QMMRCKSBBNJCMR-KMZPNFOHSA-N Angiotensin III Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)C1=CC=C(O)C=C1 QMMRCKSBBNJCMR-KMZPNFOHSA-N 0.000 abstract 1
102400000344 Angiotensin-1 Human genes 0.000 abstract 1
101800000734 Angiotensin-1 Proteins 0.000 abstract 1
102400000345 Angiotensin-2 Human genes 0.000 abstract 1
101800000733 Angiotensin-2 Proteins 0.000 abstract 1
102400000348 Angiotensin-3 Human genes 0.000 abstract 1
101800000738 Angiotensin-3 Proteins 0.000 abstract 1
108010000437 Deamino Arginine Vasopressin Proteins 0.000 abstract 1
108010000817 Leuprolide Proteins 0.000 abstract 1
108010048179 Lypressin Proteins 0.000 abstract 1
102400000050 Oxytocin Human genes 0.000 abstract 1
101800000989 Oxytocin Proteins 0.000 abstract 1
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 abstract 1
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 abstract 1
108010004977 Vasopressins Proteins 0.000 abstract 1
102000002852 Vasopressins Human genes 0.000 abstract 1
ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000007900 aqueous suspension Substances 0.000 abstract 1
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 1
239000006184 cosolvent Substances 0.000 abstract 1
229960004281 desmopressin Drugs 0.000 abstract 1
NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 abstract 1
GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 abstract 1
229960004338 leuprorelin Drugs 0.000 abstract 1
229960003837 lypressin Drugs 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 abstract 1
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 abstract 1
229960001723 oxytocin Drugs 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1
230000037317 transdermal delivery Effects 0.000 abstract 1
229960003726 vasopressin Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Radiology & Medical Imaging (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Electrotherapy Devices (AREA)
Peptides Or Proteins (AREA)

AT88101857T 1987-02-10 1988-02-09 Elektrolytische zuführung von polypeptiden durch die haut ATE135928T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/012,889 US4878892A (en)	1987-02-10	1987-02-10	Electrolytic transdermal delivery of polypeptides

Publications (1)

Publication Number	Publication Date
ATE135928T1 true ATE135928T1 (de)	1996-04-15

Family

ID=21757240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88101857T ATE135928T1 (de)	1987-02-10	1988-02-09	Elektrolytische zuführung von polypeptiden durch die haut

Country Status (9)

Country	Link
US (1)	US4878892A (de)
EP (1)	EP0278474B1 (de)
JP (1)	JPH0647016B2 (de)
KR (1)	KR970004037B1 (de)
AT (1)	ATE135928T1 (de)
AU (1)	AU608278B2 (de)
CA (1)	CA1317879C (de)
DE (1)	DE3855143T2 (de)
MX (1)	MX165338B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5032109A (en) *	1987-02-10	1991-07-16	Drug Delivery Systems Inc.	Electrolytic transdermal delivery of polypeptides
US4940456A (en) *	1987-02-10	1990-07-10	Dan Sibalis	Electrolytic transdermal delivery of proteins
US5080646A (en) *	1988-10-03	1992-01-14	Alza Corporation	Membrane for electrotransport transdermal drug delivery
KR970011449B1 (ko) *	1988-01-29	1997-07-11	더 리전트 오브 디 유니버시티 오브 캘리포니아	이온전기 영동형 비침입 검체 채취 또는 이송 장치 및 방법
US5362307A (en) *	1989-01-24	1994-11-08	The Regents Of The University Of California	Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
US5169382A (en) *	1988-10-03	1992-12-08	Alza Corporation	Membrane for electrotransport transdermal drug delivery
US5496266A (en) *	1990-04-30	1996-03-05	Alza Corporation	Device and method of iontophoretic drug delivery
US5374241A (en) *	1989-07-21	1994-12-20	Iomed, Inc.	Electrodes for iontophoresis
EP0429842B1 (de) *	1989-10-27	1996-08-28	Korea Research Institute Of Chemical Technology	Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
US5167616A (en) *	1989-12-14	1992-12-01	Alza Corporation	Iontophoretic delivery method
US5087241A (en) *	1990-07-24	1992-02-11	Empi, Inc.	Iontophoresis electrode with reservoir and injection site
US5158537A (en) *	1990-10-29	1992-10-27	Alza Corporation	Iontophoretic delivery device and method of hydrating same
US5464387A (en) *	1991-07-24	1995-11-07	Alza Corporation	Transdermal delivery device
US5356632A (en) *	1991-09-12	1994-10-18	S.I. Scientific Innovations Ltd.	Transdermal drug delivery device
US5215520A (en) *	1991-09-17	1993-06-01	Centre Internationale De Recherches Dermatologiques Galderma (C.I.R.D. Galderma)	Method for delivering an active substance topically or percutaneously
CA2087087C (en) *	1992-01-22	2000-07-18	Burton H. Sage, Jr.	Molecules for iontophoretic delivery
US5443441A (en) *	1993-03-05	1995-08-22	De Claviere; Anne Marie	Apparatus and method for transdermal delivery of cosmetic compositions
US5503632A (en) *	1994-04-08	1996-04-02	Alza Corporation	Electrotransport device having improved cathodic electrode assembly
IE960312A1 (en) *	1995-06-02	1996-12-11	Alza Corp	An electrotransport delivery device with voltage boosting¹circuit
US6425892B2 (en) *	1995-06-05	2002-07-30	Alza Corporation	Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en)	1996-05-22	2001-04-10	Alza Corporation	Device for transdermal electrotransport delivery of fentanyl and sufentanil
IE960375A1 (en) *	1995-06-05	1996-12-11	Alza Corp	Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
PT836511E (pt) *	1995-06-05	2004-08-31	Alza Corp	Dispositivo para distribuicao de fentanilo e sufentanilo por electrotransporte percutaneo
US7572252B1 (en) *	1995-06-07	2009-08-11	Alza Corporation	Electrotransport agent delivery method and apparatus
US5983130A (en) *	1995-06-07	1999-11-09	Alza Corporation	Electrotransport agent delivery method and apparatus
US5779661A (en) *	1995-12-11	1998-07-14	Physion, S.R.L.	Method of treating dysfunctional bladder syndromes by electromotive drug administration
US6718201B1 (en) *	1996-06-07	2004-04-06	Alza Corporation	Electrotransport agent delivery method and apparatus
US7153845B2 (en) *	1998-08-25	2006-12-26	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US8765177B2 (en) *	1997-09-12	2014-07-01	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
WO1999024071A1 (en) *	1997-11-12	1999-05-20	Alza Corporation	Method for decreasing self-association of polypeptides
KR100247558B1 (ko)	1997-11-24	2000-05-01	김충섭	사이클로덱스트린을 이용한 이온토포레시스 개선방법
US6163720A (en) *	1997-12-18	2000-12-19	Alza Corporation	Layered rate controlling membranes for use in an electrotransport device
US6374136B1 (en) *	1997-12-22	2002-04-16	Alza Corporation	Anhydrous drug reservoir for electrolytic transdermal delivery device
US6475514B1 (en) *	1998-12-03	2002-11-05	Andrew Blitzer	Athletic patch
US6275728B1 (en)	1998-12-22	2001-08-14	Alza Corporation	Thin polymer film drug reservoirs
AU2001286724A1 (en) *	2000-08-24	2002-03-04	Encapsulation Systems, Inc.	Ultrasonically enhanced substance delivery method
ATE428466T1 (de) *	2000-10-26	2009-05-15	Alza Corp	Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen
US20110005507A9 (en) *	2001-01-23	2011-01-13	Rick Bagwell	Real-time control of exhaust flow
US6908448B2 (en) *	2001-08-24	2005-06-21	Dermisonics, Inc.	Substance delivery device
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
DE10228680A1 (de) *	2002-06-27	2004-01-22	Holden Development Limited, Tortola	Grundlage für transdermale Formulierungen (PTF)
JP2006518640A (ja) *	2003-02-19	2006-08-17	セカンドステージベンチャーズインコーポレイテッド	経皮的薬物送達方法及び装置
WO2004073647A2 (en) *	2003-02-19	2004-09-02	Second Stage Ventures, Inc.	Ultrasonically enhanced saline treatment for burn damaged skin
CA2828718C (en)	2004-07-23	2016-05-03	Oy Halton Group Ltd.	Improvements for control of exhaust systems
US8197844B2 (en)	2007-06-08	2012-06-12	Activatek, Inc.	Active electrode for transdermal medicament administration
US8399410B2 (en) *	2007-08-06	2013-03-19	Allergan, Inc.	Methods and devices for desmopressin drug delivery
US8862223B2 (en)	2008-01-18	2014-10-14	Activatek, Inc.	Active transdermal medicament patch and circuit board for same
DK3085381T3 (en)	2008-05-21	2018-05-28	Ferring Bv	ORODISPERSIBLE DESMOPRESSIN TO INCREASE THE INITIAL PERIOD OF SLEEP UNDERSTANDED BY NEW TURRY
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
US7883487B2 (en)	2008-06-16	2011-02-08	Shantha Totada R	Transdermal local anesthetic patch with injection port
WO2010147981A1 (en)	2009-06-18	2010-12-23	Allergan, Inc.	Safe desmopressin administration
US8428708B1 (en)	2012-05-21	2013-04-23	Incline Therapeutics, Inc.	Self-test for analgesic product
US8781571B2 (en)	2011-03-31	2014-07-15	Incline Therapeutics, Inc.	Switch validation circuit and method
US8428709B1 (en)	2012-06-11	2013-04-23	Incline Therapeutics, Inc.	Current control for electrotransport drug delivery
US9731121B2 (en)	2011-03-31	2017-08-15	Incline Therapeutics, Inc.	Switch validation circuit and method
US9928115B2 (en)	2015-09-03	2018-03-27	Apple Inc.	Hardware migration between dissimilar cores

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3163166A (en) *	1961-04-28	1964-12-29	Colgate Palmolive Co	Iontophoresis apparatus
DK140801B (da) *	1975-01-15	1979-11-19	Nordisk Insulinlab	Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
US4141359A (en) *	1976-08-16	1979-02-27	University Of Utah	Epidermal iontophoresis device
US4218255A (en) *	1976-08-30	1980-08-19	University Of Dayton	Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
US4250878A (en) *	1978-11-22	1981-02-17	Motion Control, Inc.	Non-invasive chemical species delivery apparatus and method
US4291015A (en) *	1979-08-14	1981-09-22	Key Pharmaceuticals, Inc.	Polymeric diffusion matrix containing a vasodilator
JPS5810066A (ja) *	1981-07-10	1983-01-20	株式会社アドバンス	イオントフオレ−ゼ用プラスタ−構造体
US4459226A (en) *	1982-02-26	1984-07-10	Eli Lilly And Company	Process for recovering insulin
US4475916A (en) *	1982-03-18	1984-10-09	Merck & Co., Inc.	Osmotic drug delivery system
EP0092015A1 (de) *	1982-04-16	1983-10-26	Roland Brodard	Ionisierungsvorrichtung
US4639244A (en) *	1983-05-03	1987-01-27	Nabil I. Rizk	Implantable electrophoretic pump for ionic drugs and associated methods
US4710497A (en) *	1983-05-20	1987-12-01	Nitto Electric Industrial Co., Ltd.	Method for percutaneously administering physiologically active agents
US4622031A (en) *	1983-08-18	1986-11-11	Drug Delivery Systems Inc.	Indicator for electrophoretic transcutaneous drug delivery device
US4557723A (en) *	1983-08-18	1985-12-10	Drug Delivery Systems Inc.	Applicator for the non-invasive transcutaneous delivery of medicament
US4640689A (en) *	1983-08-18	1987-02-03	Drug Delivery Systems Inc.	Transdermal drug applicator and electrodes therefor
US4704282A (en) *	1984-06-29	1987-11-03	Alza Corporation	Transdermal therapeutic system having improved delivery characteristics
US4725439A (en) *	1984-06-29	1988-02-16	Alza Corporation	Transdermal drug delivery device
US4624665A (en) *	1984-10-01	1986-11-25	Biotek, Inc.	Method of transdermal drug delivery
US4702732A (en) *	1984-12-24	1987-10-27	Trustees Of Boston University	Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US4713244A (en) *	1985-08-16	1987-12-15	Bausch & Lomb Incorporated	Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
US4752285B1 (en) *	1986-03-19	1995-08-22	Univ Utah Res Found	Methods and apparatus for iontophoresis application of medicaments
IE60941B1 (en) *	1986-07-10	1994-09-07	Elan Transdermal Ltd	Transdermal drug delivery device

1987
- 1987-02-10 US US07/012,889 patent/US4878892A/en not_active Expired - Lifetime
1988
- 1988-01-29 AU AU10984/88A patent/AU608278B2/en not_active Ceased
- 1988-02-03 KR KR1019880000989A patent/KR970004037B1/ko not_active Expired - Fee Related
- 1988-02-09 DE DE3855143T patent/DE3855143T2/de not_active Expired - Fee Related
- 1988-02-09 JP JP63028618A patent/JPH0647016B2/ja not_active Expired - Fee Related
- 1988-02-09 EP EP88101857A patent/EP0278474B1/de not_active Expired - Lifetime
- 1988-02-09 AT AT88101857T patent/ATE135928T1/de not_active IP Right Cessation
- 1988-02-10 CA CA000558558A patent/CA1317879C/en not_active Expired - Fee Related
- 1988-02-10 MX MX010367A patent/MX165338B/es unknown

Also Published As

Publication number	Publication date
EP0278474B1 (de)	1996-03-27
US4878892A (en)	1989-11-07
KR970004037B1 (ko)	1997-03-24
JPS63200775A (ja)	1988-08-19
CA1317879C (en)	1993-05-18
AU608278B2 (en)	1991-03-28
MX165338B (es)	1992-11-05
DE3855143D1 (de)	1996-05-02
KR880009632A (ko)	1988-10-04
AU1098488A (en)	1988-08-11
DE3855143T2 (de)	1996-10-31
JPH0647016B2 (ja)	1994-06-22
EP0278474A1 (de)	1988-08-17

Legal Events

Date	Code	Title	Description
1996-11-15	UEP	Publication of translation of european patent specification
2003-11-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE135928T1 (de)	1996-04-15	Elektrolytische zuführung von polypeptiden durch die haut
NO901311L (no)	1990-03-21	Adheson-varianter.
JP2001522793A (ja)	2001-11-20	経皮電気輸送送達用の緩衝処理された薬物処方物
DE69629628D1 (de)	2003-10-02	Schnittstelle für Iontophorese
DE2963513D1 (en)	1982-09-30	Non-invasive chemical species delivery apparatus
ATE79036T1 (de)	1992-08-15	Transdermale, elektrolytische zufuehrung von proteinen.
ES2106735T3 (es)	1997-11-16	Tratamiento de desordenes mediante la aplicacion de factores de crecimiento de tipo de insulina y analogos.
DE3587941D1 (de)	1994-12-01	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE69031083D1 (de)	1997-08-21	Gerät zur iontophoretischen verabreichung von medikamenten
DK0607156T3 (da)	1997-04-07	Fremgangsmåde til fremstilling af konserverede lægemidler indeholdende humane proteiner til infusions- eller injektionsformål
EP0747092A3 (de)	1998-04-08	Lösungsflüssigkeit für durch Iontophorese zugeführte Medikamente
ATE184206T1 (de)	1999-09-15	Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
ATE187335T1 (de)	1999-12-15	Verwendung von diätetischen molkeproteinen zur behandlung von hiv seropositiven individuen
ES2095929T3 (es)	1997-03-01	Dispositivo iontoforetico que emplea un regulador del regimen.
DE59206619D1 (de)	1996-07-25	Wässrige Peritonealdialyse-Lösung
IL87391A0 (en)	1989-01-31	Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
AU703986B2 (en)	1999-04-01	Iontophoresis electrode structure
DE69010518D1 (de)	1994-08-18	Wässerige Desmopressin-CMC enthaltende Arzneizubereitung.
DE69534738D1 (de)	2006-04-06	Leukocyten-aktivierender Faktor
Derow et al.	1953	Electrophoretic behavior of acid phosphatase in human prostatic extracts
ATE93731T1 (de)	1993-09-15	Protein enthaltende waesserige loesungen.
DE3856592D1 (de)	2006-09-21	Adhäsionsvarianten
ATA81987A (de)	1989-07-15	Verfahren zur bestimmung des aktuellen pegels von cyclosporin-a bzw. des diesem verwandter immunsuppressiva sowie jenes deren biologisch aktiver metaboliten im blut
JPH0616535A (ja)	1994-01-25	イオントフォレーゼ用インターフェイス
JPS52148487A (en)	1977-12-09	Filter membrane of hollow fiber